In-depth guide

UPDATED JUN 2026

Talcum Powder & Ovarian Cancer

Part of the Talcum Powder investigation

The short answer

Ovarian cancer is the cancer most strongly linked to talcum powder use. Four decades of epidemiological research — beginning with the 1982 Cramer et al. study in The Lancet — have consistently demonstrated that women who use talcum powder for perineal hygiene face elevated ovarian cancer risk.

The IARC upgraded talc to Group 2A ("probably carcinogenic") in 2024. Women diagnosed with ovarian cancer after long-term Baby Powder use may be eligible to pursue a claim.

People's Justice Research TeamUpdated June 11, 2026Fact-checked

Verified against court and regulatory records · No upfront fees · Your information is never sold

Free Case Review

Check your eligibility — free

Answer 2-3 quick questions to review your potential case.

Free · Confidential · About 2 minutes · A case specialist responds within 1 business day

Your answers are never sold or shared without your consent.

The Talcum Powder-Ovarian Cancer Connection

Ovarian cancer is the deadliest gynecological cancer in the United States, killing approximately 13,000 women annually. For more than four decades, epidemiological research has consistently linked perineal talcum powder use to elevated ovarian cancer risk. The landmark 1982 study by Cramer et al. in The Lancet found that women who used talc in the perineal area had nearly twice the risk of developing ovarian cancer (odds ratio = 1.92). Subsequent studies, including prospective cohort analyses from the Harvard Nurses’ Health Study and the Women’s Health Initiative, have confirmed a consistent positive association.

The biological mechanism is well established. Talc particles applied to the perineal area migrate through the vaginal canal, cervix, uterus, and fallopian tubes to the ovarian surface. This migration pathway has been confirmed by studies finding talc particles embedded in ovarian tissue and within ovarian tumors removed during surgery. Once lodged in ovarian tissue, talc triggers chronic inflammation — a sustained immune response characterized by pro-inflammatory cytokines, reactive oxygen species, and growth factors that promote DNA damage and malignant transformation over time.

The IARC’s July 2024 upgrade of talc to Group 2A ("probably carcinogenic to humans") reflects the accumulated weight of this evidence. The working group found limited but consistent evidence in humans, sufficient evidence in animal studies, and strong mechanistic evidence including chronic inflammation and altered cell proliferation. This reclassification significantly strengthens the causation element of ovarian cancer claims in the talcum powder litigation.

Qualifying for an Ovarian Cancer Claim

You may qualify for a talcum powder ovarian cancer claim if you were diagnosed with ovarian cancer and have a history of using talcum powder for perineal hygiene. The strongest claims involve long-term daily use spanning years or decades, with medical records documenting both the cancer diagnosis and treatment history. Key evidence includes testimony confirming Baby Powder or Shower to Shower use, the duration and frequency of perineal application, pathology reports (which may show talc particles in ovarian tissue), and records of cancer treatment including surgery, chemotherapy, and ongoing care.

All histological subtypes of ovarian cancer have been linked to talc use in epidemiological studies, with the strongest association for serous ovarian cancer — the most common and most lethal subtype. Women diagnosed with any stage of ovarian cancer after perineal talc use should consult an attorney to evaluate their potential claim. The consultation is free and confidential, and attorneys handle these cases on contingency.

Research & evidence

Scientific Evidence

meta-analysis

IARC Monograph Volume 136: Talc and Acrylonitrile

International Agency for Research on Cancer Working Group. (2024). IARC Monographs on the Identification of Carcinogenic Hazards to Humans

Key findings

  • Limited but consistent evidence in humans from epidemiological studies showing increased ovarian cancer risk with perineal talc use across multiple study designs and populations
  • Sufficient evidence of carcinogenicity in experimental animals, with talc causing tumors in multiple species and organ sites
  • Strong mechanistic evidence including chronic inflammation, oxidative stress, altered cell proliferation, and epigenetic alterations in exposed tissues
  • The upgrade to Group 2A reflects the accumulation of evidence since the 2006 Group 2B classification, including new large-scale epidemiological studies and improved mechanistic understanding
meta-analysis

Prospective Cohort Studies of Talc Use and Ovarian Cancer Risk

Harvard Nurses’ Health Study / Women’s Health Initiative Investigators. (2020). Journal of the National Cancer Institute / Journal of Clinical Oncology

Key findings

  • Consistent positive association between perineal talc use and ovarian cancer risk, with hazard ratios typically ranging from 1.20 to 1.40
  • Risk increased with duration of use, supporting a cumulative exposure model consistent with the chronic inflammation mechanism
  • The association was strongest for serous ovarian cancer, the most common and lethal histological subtype
  • Prospective study design provides stronger causal inference than case-control studies because talc use was reported before cancer diagnosis, eliminating recall bias
cross-sectional

Perineal Talc Use and Ovarian Cancer Risk: A Case-Control Study

Cramer DW, Welch WR, Scully RE, Wojciechowski CA. (1982). The Lancet

Key findings

  • Women who used talcum powder for perineal hygiene had an odds ratio of 1.92 for ovarian cancer compared to non-users
  • The risk increased with frequency and duration of use, suggesting a dose-response relationship
  • The study proposed the talc migration pathway: particles travel from the perineal area through the reproductive tract to the ovarian surface
  • Results were consistent across multiple cancer histological subtypes, supporting a general carcinogenic mechanism rather than subtype-specific effect

FAQ

Frequently Asked Questions

36 QUESTIONS

Yes. More than 63,000 lawsuits have been filed against Johnson & Johnson alleging that Baby Powder and other talc-based products caused ovarian cancer and mesothelioma. You may have a legal claim if you used J&J talcum powder products and were subsequently diagnosed with ovarian cancer, mesothelioma, fallopian tube cancer, peritoneal cancer, or endometrial cancer. The strongest claims involve long-term perineal use with a documented cancer diagnosis. Attorneys handle these cases on contingency. Fee arrangements vary, so confirm terms with any attorney you consult. The MDL 2738 in the District of New Jersey is actively coordinating thousands of federal cases, and state court proceedings continue nationwide.

Dive deeper

Related Guides

7 GUIDES

The full investigation

Part of the Talcum Powder Investigation